Principles for designing future regimens for multidrug-resistant tuberculosis

Fewer than 20% of patients with multidrug-resistant (MDR) tuberculosis are receiving treatment and there is an urgent need to scale up treatment programmes. One of the biggest barriers to scale-up is the treatment regimen, which is lengthy, complex, ineffective, poorly tolerated and expensive. For t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Brigden, Grania, Nyang’wa, Bern-Thomas, du Cros, Philipp, Varaine, Francis, Hughes, Jennifer, Rich, Michael, Horsburgh, C Robert, Mitnick, Carole D, Nuermberger, Eric, McIlleron, Helen, Phillips, Patrick PJ, Balasegaram, Manica
Natura: Artigo
Lingua:Inglês
Pubblicazione: World Health Organization 2014
Soggetti:
Policy & Practice
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3865549/
https://ncbi.nlm.nih.gov/pubmed/24391302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2471/BLT.13.122028
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi